{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:25:47Z","timestamp":1759206347939},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Guangdong Province, China","award":["2020A1515011249"],"award-info":[{"award-number":["2020A1515011249"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities of China","doi-asserted-by":"crossref","award":["21620406"],"award-info":[{"award-number":["21620406"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Program of Guangzhou, China","award":["2023A03J0577"],"award-info":[{"award-number":["2023A03J0577"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Core biomarkers for Alzheimer\u2019s disease (AD), such as A\u03b242 and tau, have demonstrated high prognostic accuracy but do not fully capture the complex pathophysiology of AD. In this study, our objective was to identify novel cerebrospinal fluid (CSF) biomarkers using proteomics across the entire AD continuum to predict conversion to AD and explore their involvement in AD pathogenesis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cohort of 186 cognitively normal (CN), 127 subjective memory complaint (SMC), 79 early mild cognitive impairment (EMCI), 249 late MCI (LMCI), and 132 AD individuals was analyzed, with a follow-up period of over 3 years for non-AD participants. CSF 65 peptides, as well as hippocampal and entorhinal volumes were analyzed, and cognitive function was evaluated using the 13-item cognitive subscale of the Alzheimer\u2019s Disease Assessment Scale (ADAS-Cog 13). Cox proportional hazards models and mediation analysis were performed to investigate associations and causal relationships.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the follow-up, approximately one-fourth (146\/580) of the non-AD participants progressed to AD. After adjusting for baseline diagnosis (CN to LMCI) and other variables, multivariable Cox regression analysis identified three peptides (VAELEDEK, VSFELFADK, and VVSSIEQK) as significant predictors of conversion to AD. Incorporating these three peptides into the initial model significantly improved the C-statistic from 0.82 to 0.85 for predicting AD conversion, surpassing the predictive ability of A\u03b242 and P-tau. Moreover, hippocampal and entorhinal volumes mediated 30.3\u201353.8% of the association between the three peptides and ADAS-Cog 13 scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings underscore the potential of these three peptides as robust prognostic biomarker candidates for AD conversion across the entire AD continuum, with a mechanism involving the mediation of hippocampal and entorhinal volumes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-024-05104-z","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T17:02:11Z","timestamp":1717693331000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential prognostic value of CSF-targeted proteomics across the Alzheimer\u2019s disease continuum"],"prefix":"10.1186","volume":"24","author":[{"given":"Bingdong","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yitong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leiyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingze","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"issue":"10284","key":"5104_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390.","journal-title":"Lancet"},{"issue":"4","key":"5104_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CJ Jack","year":"2018","unstructured":"Jack CJ, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"5104_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.24272\/j.issn.2095-8137.2021.479","volume":"43","author":"TA Kim","year":"2022","unstructured":"Kim TA, Syty MD, Wu K, Ge S. Adult hippocampal neurogenesis and its impairment in Alzheimer\u2019s disease. Zool Res. 2022;43(3):481\u201396.","journal-title":"Zool Res"},{"issue":"2","key":"5104_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tins.2022.11.006","volume":"46","author":"KM Igarashi","year":"2023","unstructured":"Igarashi KM. Entorhinal cortex dysfunction in Alzheimer\u2019s disease. Trends Neurosci. 2023;46(2):124\u201336.","journal-title":"Trends Neurosci"},{"issue":"1","key":"5104_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jalz.2018.05.006","volume":"15","author":"J Cummings","year":"2019","unstructured":"Cummings J. The National Institute on Aging-Alzheimer\u2019s Association Framework on Alzheimer\u2019s disease: application to clinical trials. Alzheimers Dement. 2019;15(1):172\u20138.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"5104_CR6","doi-asserted-by":"publisher","first-page":"e1137","DOI":"10.1212\/WNL.0000000000200040","volume":"98","author":"N Mattsson-Carlgren","year":"2022","unstructured":"Mattsson-Carlgren N, Grinberg LT, Boxer A, Ossenkoppele R, Jonsson M, Seeley W, et al. Cerebrospinal fluid biomarkers in autopsy-confirmed Alzheimer disease and frontotemporal lobar degeneration. Neurology. 2022;98(11):e1137\u201350.","journal-title":"Neurology"},{"issue":"1","key":"5104_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41386-020-00840-3","volume":"46","author":"S Rayaprolu","year":"2021","unstructured":"Rayaprolu S, Higginbotham L, Bagchi P, Watson CM, Zhang T, Levey AI, et al. Systems-based proteomics to resolve the biology of Alzheimer\u2019s disease beyond amyloid and tau. Neuropsychopharmacol. 2021;46(1):98\u2013115.","journal-title":"Neuropsychopharmacol"},{"issue":"12","key":"5104_CR8","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s11010-023-04702-6","volume":"478","author":"H Guo","year":"2023","unstructured":"Guo H, Chen R, Li P, Yang Q, He Y. ZBP1 mediates the progression of Alzheimer\u2019s disease via pyroptosis by regulating IRF3. Mol Cell Biochem. 2023;478(12):2849\u201360.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"5104_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH. Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics. Inflammation. 2023;46(1):1\u201317.","journal-title":"Inflammation"},{"issue":"18","key":"5104_CR10","doi-asserted-by":"publisher","first-page":"14225","DOI":"10.3390\/ijms241814225","volume":"24","author":"P Liu","year":"2023","unstructured":"Liu P, Li L, He F, Meng F, Liu X, Su Y, et al. Identification of candidate biomarkers of Alzheimer\u2019s disease via multiplex cerebrospinal fluid and serum proteomics. Int J Mol Sci. 2023;24(18):14225.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5104_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-020-00384-6","volume":"15","author":"H Wang","year":"2020","unstructured":"Wang H, Dey KK, Chen PC, Li Y, Niu M, Cho JH, et al. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer\u2019s disease. Mol Neurodegener. 2020;15(1):43.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"5104_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"E Johnson","year":"2020","unstructured":"Johnson E, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020;26(5):769\u201380.","journal-title":"Nat Med"},{"issue":"3","key":"5104_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/10408363.2017.1299682","volume":"54","author":"P Bastos","year":"2017","unstructured":"Bastos P, Ferreira R, Manadas B, Moreira PI, Vitorino R. Insights into the human brain proteome: disclosing the biological meaning of protein networks in cerebrospinal fluid. Crit Rev Clin Lab Sci. 2017;54(3):185\u2013204.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"43","key":"5104_CR14","doi-asserted-by":"publisher","first-page":"eaaz9360","DOI":"10.1126\/sciadv.aaz9360","volume":"6","author":"L Higginbotham","year":"2020","unstructured":"Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M, et al. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease. Sci Adv. 2020;6(43):eaaz9360.","journal-title":"Sci Adv"},{"key":"5104_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12014-020-09285-8","volume":"17","author":"M Zhou","year":"2020","unstructured":"Zhou M, Haque RU, Dammer EB, Duong DM, Ping L, Johnson E, et al. Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer\u2019s disease. Clin Proteom. 2020;17:19.","journal-title":"Clin Proteom"},{"issue":"1","key":"5104_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13195-022-01060-1","volume":"14","author":"KR Thomas","year":"2022","unstructured":"Thomas KR, Weigand AJ, Edwards LC, Edmonds EC, Bangen KJ, Ortiz G, et al. Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint. Alzheimers Res Ther. 2022;14(1):114.","journal-title":"Alzheimers Res Ther"},{"key":"5104_CR17","first-page":"5336273","volume":"2023","author":"M Behzad","year":"2023","unstructured":"Behzad M, Zirak N, Madani GH, Baidoo L, Rezaei A, Karbasi S, et al. CSF-targeted proteomics indicate amyloid-beta ratios in patients with Alzheimer\u2019s dementia spectrum. Int J Alzheimers Dis. 2023;2023:5336273.","journal-title":"Int J Alzheimers Dis"},{"issue":"1","key":"5104_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41597-023-02158-3","volume":"10","author":"CM Watson","year":"2023","unstructured":"Watson CM, Dammer EB, Ping L, Duong DM, Modeste E, Carter EK, et al. Quantitative mass spectrometry analysis of cerebrospinal fluid protein biomarkers in Alzheimer\u2019s disease. Sci Data. 2023;10(1):261.","journal-title":"Sci Data"},{"issue":"8","key":"5104_CR19","doi-asserted-by":"publisher","first-page":"e135365","DOI":"10.1371\/journal.pone.0135365","volume":"10","author":"RC Hendrickson","year":"2015","unstructured":"Hendrickson RC, Lee AY, Song Q, Liaw A, Wiener M, Paweletz CP, et al. High resolution discovery proteomics reveals candidate disease progression markers of Alzheimer\u2019s disease in human cerebrospinal fluid. PLoS ONE. 2015;10(8):e135365.","journal-title":"PLoS ONE"},{"issue":"712","key":"5104_CR20","doi-asserted-by":"publisher","first-page":"g4122","DOI":"10.1126\/scitranslmed.adg4122","volume":"15","author":"R Haque","year":"2023","unstructured":"Haque R, Watson CM, Liu J, Carter EK, Duong DM, Lah JJ, et al. A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer\u2019s disease. Sci Transl Med. 2023;15(712):g4122.","journal-title":"Sci Transl Med"},{"issue":"10","key":"5104_CR21","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1212\/WNL.0000000000201658","volume":"100","author":"S Chapman","year":"2023","unstructured":"Chapman S, Renteria MA, Dworkin JD, Garriga SM, Barker MS, Avila-Rieger J, et al. Association of subjective cognitive decline with progression to dementia in a cognitively unimpaired multiracial community sample. Neurology. 2023;100(10):e1020\u20137.","journal-title":"Neurology"},{"issue":"2","key":"5104_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jagp.2019.08.011","volume":"28","author":"H Lavretsky","year":"2020","unstructured":"Lavretsky H, Laird KT, Krause-Sorio B, Heimberg BF, Yeargin J, Grzenda A, et al. A randomized double-blind placebo-controlled trial of combined escitalopram and memantine for older adults with major depression and subjective memory complaints. Am J Geriatr Psychiatry. 2020;28(2):178\u201390.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"12","key":"5104_CR23","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/alz.12353","volume":"17","author":"O Libiger","year":"2021","unstructured":"Libiger O, Shaw LM, Watson MH, Nairn AC, Umana KL, Biarnes MC, et al. Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer\u2019s disease. Alzheimers Dement. 2021;17(12):1976\u201387.","journal-title":"Alzheimers Dement"},{"key":"5104_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bbi.2016.07.148","volume":"58","author":"A Swanson","year":"2016","unstructured":"Swanson A, Willette AA. Neuronal pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer\u2019s disease spectrum. Brain Behav Immun. 2016;58:201\u20138.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"5104_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12035-019-01754-y","volume":"57","author":"Q Gu","year":"2020","unstructured":"Gu Q, Cuevas E, Raymick J, Kanungo J, Sarkar S. Downregulation of 14-3-3 proteins in Alzheimer\u2019s disease. Mol Neurobiol. 2020;57(1):32\u201340.","journal-title":"Mol Neurobiol"},{"issue":"5","key":"5104_CR26","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/alz.12809","volume":"19","author":"J Nilsson","year":"2023","unstructured":"Nilsson J, Cousins K, Gobom J, Portelius E, Chen-Plotkin A, Shaw LM, et al. Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer\u2019s disease and other neurodegenerative disorders. Alzheimers Dement. 2023;19(5):1775\u201384.","journal-title":"Alzheimers Dement"},{"key":"5104_CR27","doi-asserted-by":"publisher","first-page":"e23798","DOI":"10.7554\/eLife.23798","volume":"6","author":"MF Xiao","year":"2017","unstructured":"Xiao MF, Xu D, Craig MT, Pelkey KA, Chien CC, Shi Y, et al. NPTX2 and cognitive dysfunction in Alzheimer\u2019s disease. Elife. 2017;6:e23798.","journal-title":"Elife"},{"issue":"14","key":"5104_CR28","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.1523\/JNEUROSCI.2548-14.2015","volume":"35","author":"J Figueiro-Silva","year":"2015","unstructured":"Figueiro-Silva J, Gruart A, Clayton KB, Podlesniy P, Abad MA, Gasull X, et al. Neuronal pentraxin 1 negatively regulates excitatory synapse density and synaptic plasticity. J Neurosci. 2015;35(14):5504\u201321.","journal-title":"J Neurosci"},{"issue":"6286","key":"5104_CR29","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712\u20136.","journal-title":"Science"},{"issue":"689","key":"5104_CR30","doi-asserted-by":"publisher","first-page":"eadf0141","DOI":"10.1126\/scitranslmed.adf0141","volume":"15","author":"J Zhou","year":"2023","unstructured":"Zhou J, Wade SD, Graykowski D, Xiao MF, Zhao B, Giannini L, et al. The neuronal pentraxin NPTX2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Sci Transl Med. 2023;15(689):eadf0141.","journal-title":"Sci Transl Med"},{"issue":"7399","key":"5104_CR31","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin a. Nature. 2012;485(7399):512\u20136.","journal-title":"Nature"},{"issue":"8","key":"5104_CR32","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00775-021-01903-6","volume":"26","author":"S Yoshida","year":"2021","unstructured":"Yoshida S, Yamamoto A, Masumoto H, Fuchigami T, Toriba A, Haratake M, et al. Peptidyl-prolyl cis-trans isomerase a participates in the selenium transport into the rat brain. J Biol Inorg Chem. 2021;26(8):933\u201345.","journal-title":"J Biol Inorg Chem"},{"issue":"5","key":"5104_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1039\/c3mt00035d","volume":"5","author":"M Haratake","year":"2013","unstructured":"Haratake M, Yoshida S, Mandai M, Fuchigami T, Nakayama M. Elevated amyloid-beta plaque deposition in dietary selenium-deficient Tg2576 transgenic mice. Metallomics. 2013;5(5):479\u201383.","journal-title":"Metallomics"},{"issue":"522","key":"5104_CR34","doi-asserted-by":"publisher","first-page":"eaap8734","DOI":"10.1126\/scisignal.aap8734","volume":"11","author":"NR Stallings","year":"2018","unstructured":"Stallings NR, O\u2019Neal MA, Hu J, Kavalali ET, Bezprozvanny I, Malter JS. Pin1 mediates A\u03b242-induced dendritic spine loss. Sci Signal. 2018;11(522):eaap8734.","journal-title":"Sci Signal"},{"key":"5104_CR35","doi-asserted-by":"publisher","first-page":"8407609","DOI":"10.1155\/2018\/8407609","volume":"2018","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhou Y. 14-3-3 proteins in glutamatergic synapses. Neural Plast. 2018;2018:8407609.","journal-title":"Neural Plast"},{"issue":"2","key":"5104_CR36","first-page":"152","volume":"3","author":"M Foote","year":"2012","unstructured":"Foote M, Zhou Y. 14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol. 2012;3(2):152\u201364.","journal-title":"Int J Biochem Mol Biol"},{"key":"5104_CR37","doi-asserted-by":"publisher","first-page":"awae032","DOI":"10.1093\/brain\/awae032","volume":"7","author":"J Nilsson","year":"2024","unstructured":"Nilsson J, Pichet BA, Palmqvist S, Brum WS, Janelidze S, Ashton NJ, et al. Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases. Brain. 2024;7:awae032.","journal-title":"Brain"},{"issue":"18","key":"5104_CR38","doi-asserted-by":"publisher","first-page":"e2007785118","DOI":"10.1073\/pnas.2007785118","volume":"118","author":"N Hensel","year":"2021","unstructured":"Hensel N, Cieri F, Santonicola P, Tapken I, Schuning T, Taiana M, et al. Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy. Proc Natl Acad Sci U S A. 2021;118(18):e2007785118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5104_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-publhealth-032315-021402","volume":"37","author":"TJ VanderWeele","year":"2016","unstructured":"VanderWeele TJ. Mediation analysis: a practitioner\u2019s guide. Annu Rev Public Health. 2016;37:17\u201332.","journal-title":"Annu Rev Public Health"},{"issue":"2","key":"5104_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13205-022-03123-4","volume":"12","author":"YL Rao","year":"2022","unstructured":"Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A. Hippocampus and its involvement in Alzheimer\u2019s disease: a review. 3 Biotech. 2022;12(2):55.","journal-title":"3 Biotech"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05104-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-024-05104-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05104-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T17:03:08Z","timestamp":1717693388000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-024-05104-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5104"],"URL":"https:\/\/doi.org\/10.1186\/s12877-024-05104-z","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"assertion":[{"value":"4 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review boards of all participating ADNI sites reviewed and approved the data collection protocols provided by ADNI.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"501"}}